By use of moderate-to-high dosages, complete
301 Moved Permanently Griseofulvin (GF; FDA-approved treatment) inhibits CC, and combined with radiation treatment (RT), resulted in a significant increase in the number of NSCLC cells with
territory were offered admission to the Johns Hopkins University undergraduate Class
Johns